|Year : 2015 | Volume
| Issue : 42 | Page : 283-291
Attenuation of reactive oxygen/nitrogen species with suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by bark extract of Buchanania lanzan
Shailasree Sekhar1, KK Sampath-Kumara2, SR Niranjana2, HS Prakash2
1 Institution of Excellence, Vijnana Bhavana, Mysore, Karnataka, India
2 Department of Studies in Biotechnology, University of Mysore, Mysore, Karnataka, India
|Date of Submission||07-Mar-2014|
|Date of Acceptance||09-Jun-2014|
|Date of Web Publication||12-Mar-2015|
H S Prakash
Department of Studies in Biotechnology, University of Mysore, Mysore - 570 006, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Oxidative stress is one of the most critical factors implicated in disease conditions. Buchanania lanzan Spr. (Anacardiaceae) bark powder preparation has been reported for treating an inflammatory condition in the Ayurvedic Pharmacopoeia of India. Objective: In the present study, we investigate the effect of the bark methanol extract (BLM) on reactive oxygen/nitrogen species (ROS/RNS), the expression of protein and mRNA of inducible nitric oxide synthase (iNOS) in RAW 264.7 macrophages stimulated with lipopolysaccharide (LPS) and sodium nitroprusside (SNP) to provide scientific validation of the above said medicinal property. Materials and Methods: The capacity to quench ROS and RNS was evaluated by 5-(and-6) chloromethyl-20,70-dichlorodihydrofluorescein diacetate acetyl ester fluorescence and nitrite estimations in LPS/SNP-stimulated macrophages respectively. The protein and transcript expression of iNOS was evaluated through Western Blot and reverse transcription-polymerase chain reaction (RT-PCR) analysis respectively. Results: Macrophages pretreated with BLM (>100 μg/mL) for 24 h, stimulated with LPS for the last 18 h of experimental duration recorded a significantly (P < 0.05) reduced levels of ROS (3.45-fold) against LPS-stimulated conditions (5.7-fold). SNP-stimulation resulted in increased NO accumulation (17-fold) which was neutralized by BLM at >100 μg/ml (1.6-fold) credited to a reduced protein and mRNA expression of iNOS as recorded by Western blots and RT-PCR results respectively. The reversed-phase liquid chromatography-diode array detection analysis identified the presence of 4-hydroxybenzoic acid, quercetin and p-coumaric acid (Rt values 5.444, 5.569 and 9.580 respectively). Conclusions: The potential of BLM inhibiting ROS/RNS production validates the medical use of bark, could find beneficial application under conditions of immune stimulation and/or bacterial infection.
Keywords: Buchanania lanzan, flow cytometer, inducible nitric oxide synthase, lipopolysaccharide/sodium nitroprusside-stimulated oxidative stress, RAW 264.7 macrophages, reactive oxygen/nitrogen species
|How to cite this article:|
Sekhar S, Sampath-Kumara K K, Niranjana S R, Prakash H S. Attenuation of reactive oxygen/nitrogen species with suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by bark extract of Buchanania lanzan. Phcog Mag 2015;11:283-91
|How to cite this URL:|
Sekhar S, Sampath-Kumara K K, Niranjana S R, Prakash H S. Attenuation of reactive oxygen/nitrogen species with suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by bark extract of Buchanania lanzan. Phcog Mag [serial online] 2015 [cited 2022 Jun 26];11:283-91. Available from: http://www.phcog.com/text.asp?2015/11/42/283/153080
| Introduction|| |
Oxygen partially reduced during normal metabolism yields reactive molecules termed reactive oxygen species (ROS) including hydrogen peroxide (H 2 O 2 ), superoxide radical etc., Overload of ROS results in oxidative stress that is detrimental with a role in the etiology of several human degenerative diseases like cancer, neurodegenerative disorders, and inflammation.  Bacterial infection using Escherichia coli lipopolysaccharide (LPS) has been reported to cause excessive production of ROS. Upon stimulation with antigen (sodium nitroprusside; [SNP]) excessive production of nitric oxide (NO) has been reported  through expression of inducible NO synthase (iNOS). , RAW 264.7 murine macrophages have been used to study these pathological conditions in vitro. Upon stimulation these macrophages exhibit excessive accumulation of both NO and superoxide anion, whose interaction results in formation of toxic peroxynitrite (ONOO− )  resulting in septic shock,  cerebral injury,  local or systemic inflammatory disorders.  Thus, the inhibition of ROS production,  along with iNOS expression and/or activity has been identified as a therapeutic target in screening of natural products. ,,
Buchanania lanzan, Spr. (Anacardiaceae), commonly known as Chironji, has been used for treating ailments viz., to reduce granular swelling; relieve prickly heat; bark gum for treating diarrhea and intercostals pain and leaves as anti-ophidian.  Myricetin 3'- rhamnoside-3-galactoside, celidoniol, vomicine, and pinitol are reported.  Immunostimulant properties for B. lanzan with a capacity to enhanced macrophage migration index, hemagglutinating antibody titers, plaque-forming cell counts as parameters of humoral immunity was observed and efficacy against cyclophosphamide induced genotoxicity and oxidative stress in mice has been reported.  Earlier studies report on the use of methanolic extract of leaves,  kernel,  and roots  with anti-inflammatory, antioxidant and analgesic properties using in vivo rat paw edema model is available.
The Ayurvedic pharmacopoeia of India describes oral intake of 5-10 g dried stem bark to cure fevers and inflammatory conditions.  In this direction, earlier studies from this laboratory have reported significant antioxidant activity (P < 0.05) to this extract with a potential to inhibit 15-lipoxygenase and human cyclooxygenase-2, the inflammatory mediators, in a dose-dependent manner.  Apart from these reports, B. lanzan bark extracts are not investigated. As there have been studies on antioxidant and anti-inflammatory mechanism, we became interested to look into the ROS and reactive nitrogen species (RNS) pathway. In this study, we report on the mechanism of B. lanzan bark methanol extract (BLM) role in LPS/SNP-stimulated macrophages, RAW 264.7 cells, providing evidence for it to be with potential therapeutic value.
The intracellular ROS produced by LPS-stimulated macrophages was detected and measured using ROS-sensitive fluorescent dye, 5-(and-6) chloromethyl-20,70-dichlorodihydrofluorescein diacetate acetyl ester (CM-H 2 DCFDA). , The dye enters the cells, reacts with ROS to form 2',7'-dichlorofluorescin and is trapped within the cell. The differential fluorescence was estimated by multimode plate reader and evaluated by Flow Cytometer analysis. The effect of BLM on RNS was evaluated in SNP-stimulated macrophages, by estimation of nitrite as a measure of NO, a RNS. The effect of BLM on the key enzyme for the production of iNOS was evaluated at protein and mRNA transcript levels.
| Materials and methods|| |
All chemicals used in the study were of analytical grade. β-actin, Dulbeco's modified eagle medium (DMEM), penicillin-streptomycin, trypsin, heat inactivated fetal calf serum, E. coli LPS, CM-H 2 DCFDA and SNP were from Sigma-Aldrich (St. Louis, MO, USA). Solvents used for chromatography were of high-performance liquid chromatography grade procured from Merck Biosciences (Bangalore, India). Whatman NYL 0.45 μm syringe filter was used for the filtration of samples.
The B. lanzan tree barks was collected from Kigga region of Western Ghats in Chikmaglore District of Karnataka State, India, during monsoon period (October-November)  and authenticated by taxonomist, Mr. Sampath Kumar at University of Mysore. Herbarium specimen was deposited at the Department of Studies in Biotechnology (B. lanzan # IOE LP0004). Fresh bark pieces were thoroughly washed under running tap water to remove debris and air-dried under shade. They were pulverized in a laboratory mechanical grinder to a coarse powder. Ground powder (250 g) was extracted sequentially using 500 ml of nonpolar and polar solvents in increasing polarity hexane < chloroform < methanol < water using Soxhlet apparatus by continuous hot percolation (boiling point, 52-62°C) until the solvent became colorless. The resultant solvent extracts were concentrated in a SpeedVac (Savant SPD 2010, Thermo Scientific, Germany) under reduced pressure. The methanol extract (24.48 g) exhibited potent antioxidant activity with a capacity to inhibit activities of human cyclooxygenase-2 and 15-lipoxygenase.  Hence, this fraction was selected for further investigations in the present study and is mentioned as BLM. Before the start of the experiment, BLM was solubilized in dimethylsulfoxide (DMSO).
Mouse macrophage cell line RAW 264.7 was obtained from National Center for Cell Science (Pune, India) and cultured in DMEM supplemented with fetal bovine serum (10%) containing penicillin-streptomycin (10%) at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were plated at a density of 1 × 10 4 cells/well in 25 or 75 cm 2 flasks, or in 6-or 96-well plate overnight, and treated with BLM (10, 50, 100 and 200 μg/ml) for 24 h.
Reactive oxygen species measurement
With the aim to investigate the therapeutic potential of BLM, we investigated whether it could inhibit LPS-stimulated ROS generation in RAW 264.7 cells using a fluorescent dye, CM-H 2 DCFDA. The differential fluorescence in the samples: RAW 264.7 control cells, LPS-stimulated (10 ng/ml) control and BLM pretreated LPS-stimulated samples were measured. , For testing BLM, cells were plated (1 × 10 4 cells/well) in a 6-well plate. Once the cells reached confluence (approximately 200,000 cells/well as visualized under inverted microscope), they were treated with BLM (10, 50, 100 and 200 μg/ml) for 24 h. Cells were stimulated with LPS (10 ng/ml) during the last 18 h of duration of the experiment. Fluorescent dye, CM-H 2 DCFDA (final concentration 10 μl of 20 μM) was added to cells and incubated for 30 min in CO 2 incubator to measure the intracellular ROS produced in these cells. After incubation, the cells were washed with cold-phosphate buffered saline (phosphate buffer saline [PBS]: 50 mM PBS [pH 7.2] containing 0.8% NaCl) and the fluorescence intensity of the stained cells was measured at an excitation and emission wavelength of 485 nm and 530 nm respectively (VarioSkan Flash, Thermo Fisher Scientific, Finland). Fluorescence was measure using Cell Lab Quanta SCTM flow cytometer (Beckman Coulter) Flow Cytometer and at least 10 4 cellular events were counted on FL3. The intracellular fluorescence for all the samples was recorded using Confocal Laser Scanning Microscope, LSM 710 (Carl Zeiss, Germany).
Cell proliferation assay
Cells were plated at a density of 1 × 10 4 cells/well in 96-well plate overnight, and treated with BLM (10, 50, 100 and 200 μg/ml) for 24 h. Cells were stimulated with LPS (10 ng/ml) or SNP (10 μM) during the last 18 h of treatment with BLM. At the end of the treatment period, 50 μl of 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) solution (0.5 mg/ml) was added to each well and the plate incubated for 3 h. The supernatant was aspirated, and the formazan crystals formed, solubilized in 200 μl DMSO for 30 min. The extent of reduction of MTT to formazan within cells was quantified by multimode plate reader at 550 nm (VarioSkan Flash, Thermo Fisher Scientific, Finland). In another experiment, designed to assess the viability, LPS-stimulated cells (1 × 10 4 ) were stained with calcein (AM) and/or propidium idodide (5 μl for 100 μl of culture medium with 1 × 10 4 cells) in 1 ml staining buffer and incubated for 30 min at room temperature as per manufacturers' protocol (Affymetrix, Ebioscience kit). They were washed two times with staining buffer, and the cells were read in Flow Cytometer, Cell Lab Quanta SCTM flow cytometer (Beckman Coulter) as per manufacturers' protocol.
Nitrite concentrations as a measure of reactive nitrogen species, nitric oxide levels
Nitrite production was evaluated as an indicator of NO, was measured in the supernatant of RAW 264.7 macrophages.  Briefly, the macrophages were cultured in 96-well plates with 200 ml of culture medium until cells reached confluence. In order to induce iNOS, fresh culture medium (100 μl) containing SNP, 10 μM was added. Nitrite accumulation in the medium was measured after 18 h of SNP addition. To assay the effect of BLM on nitrite production, cells were pretreated with BLM (10, 50, 100 and 200 μg/ml) for 24 h and with SNP during the last 18 h of experimental duration. Nitrite was measured by adding 100 μl of cell culture extract to 100 μl of Griess reagent (1% sulfanilamide and 0.1% naphthylenediamine in 5% phosphoric acid). After 10 min incubation, the optical density was measured at 550 nm in a microplate reader (VarioSkan Flash, Thermo Fisher Scientific, Finland). The concentrations of nitrite were calculated by comparison of absorbance of standard solutions of sodium nitrite prepared in culture medium and assayed under similar conditions.
Western blot analysis of inducible nitric oxide synthase
RAW 264.7 cells in 75 cm 2 culture flasks were incubated for 24 h with BLM (100 and 200 μg/ml) and with SNP (10 μM) for the last 18 h of the duration of the experiment. Incubations were terminated by rapid aspiration of the cell supernatant followed by washing with ice-cold PBS. Cells were lysed in PBS containing ethylenediaminetetraacetic acid (10 mM), 1% Triton X-100, phenylmethyl sulfonyl fluoride (1 mM) and 0.1% leupeptin. Total protein in RAW 264.7 cell extracts was measured by the Bradford method using bovine serum albumin as standard. Proteins (30 μg) were separated by 10% sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in a 1 mm thick 10% SDS-PAGE. For Western blot analysis, proteins separated were transferred on to nitrocellulose membranes (Millipore) using Multiphor II (LKB, Pharmacia) electrophoretic transfer apparatus according to manufacturer's protocol. The blots were blocked in 2% fat-free milk in Tris buffered saline (TBS: 10 mM Tris-HCl, pH 8.0, 150 mM NaCl). The blots were incubated for 2 h at 37°C with primary antibodies (iNOS antibodies, a polyclonal antibody against the peptide PT387 (Ac-Cys-residues 1131-1144, from the C terminus of the deduced amino acid sequence of murine iNOS),  a kind gift from Prof. Mikio Nishimura, National Institute for Basic Biology, (Okazaki, Japan). The transfer conditions used were 135 mA for 90 min. After three washes with TBS, the blots were incubated with alkaline phosphatase (ALP) conjugated goat anti-rabbit immunoglobulin G (Merck BioSciences, Bangalore, India), diluted 1:1000 for 30 min at room temperature. They were washed three times in TBS, and the blots were stained for ALP activity with nitro blue tetrazolium /5-bromo- 4-chloro-3-indolyl-phosphate (Chromos Biotech, Bangalore, India). β-actin was used as internal control.
Relative quantification of inducible nitric oxide synthase gene expression by reverse transcription-polymerase chain reaction
RAW 264.7 macrophages were cultured in 75 cm 2 flasks for RNA extraction. Once the cells reached confluence, they were treated with various concentration of BLM (50, 100 and 200 μg/ml) for 24 h and with SNP (10 μM) for the last 18 h of the experimental duration. Total RNA was extracted from control, SNP-stimulated and BLM with SNP-stimulated macrophages by RNA isolation kit (Sigma, St. Louis, MO, USA). RT was performed with equal amounts of RNA (2 μg) primed with oligo (dt) using hot start-reverse transcription-polymerase chain reaction (HS-RT-PCR) kit as per manufacturers' recommended protocol (Sigma). RT generated cDNA encoding iNOS and β-tubulin (internal standard) genes were amplified in a total volume of 20 μl of SYBR Green PCR Mastermix (Roche Diagnostics, Germany) with appropriate primers iNOS (5'-CCCTTCCGAAGTTTCTGGCAGCAGC-3' and 5'- GGCTGTCAGAGAGCCTCGTGGCTTTGG-3') and mouse α-tubulin (5'- ATGCCATCCTGCGTCTGGACCTGGC -3' and 5'- AGCATTTGCGGTGCACGATGGAGGG-3') in a Roche Light Cycler 480. The initial denaturation was performed (94°C for 10 min) and further, a 35 cycle of amplification was performed with these said parameters (94°C for 45 s, 65°C for 40 s and 70°C for 3 min) followed by a final 10 min extension at 72°C. A continuous monitoring of fluorescence for each PCR product was carried out. A single narrow peak was obtained for melting curve analysis at specific temperature. All the samples (n = 2) were analyzed, and the ΔCT method was used to quantify expression levels. Normalization was done w.r.t. housekeeping α-tubulin gene. Analysis was performed with light cycler relative quantification software.
Chromatogram of bark methanol extract extracts by reversed-phase liquid chromatography
Chromatographic analysis of BLM was performed on Waters liquid chromatographic system equipped with Waters (Milford, MA, USA) and Waters Spherisorb column (C18; 250 × 4.6 mm, 50 mm particle size) as stationary phase with photodiode array detector. Mobile phase consisting of a mixture of acetonitrile: Water (18:82) acidified with 2% acetic acid, was delivered at a flow rate of 1 ml/min. Standards (200 ppm, injection volume 10 μl) were prepared using 4-hydroxybenzoic acid (HBA), quercetin and p-coumaric acid (pCA). The BLM sample solution was prepared in the same way and at the same concentration range. Each sample was injected three times in three independent experiments.
Each experiment was carried out at least three to six times separately. The results are presented as the mean ± standard deviation of measurements. Statistical difference between control and BLM groups for all experiments was determined using Students' t-test. NO production has been indicated as absolute concentrations in μM. The comparison between the groups was considered significant if P < 0.05.
| Results|| |
Buchanania lanzan methanol extracts inhibited reactive oxygen species production
With an aim to examine BLM capacity to inhibit ROS generation in LPS-stimulated RAW-264.7 cells, they were exposed to CM-H 2 DCFDA, a fluorescent dye widely used to label ROS in macrophages. Treatment with LPS (10 ng/mL) resulted in overproduction of ROS (5.7-fold) [Figure 1]a. At the lowest concentration of BLM (10 μg/mL), ROS production was not significantly different from LPS-stimulated cells. However, a dose-dependent differential intensity of fluorescence was recorded that was significantly (P < 0.05) less in BLM pretreated (10, 50, 100 and 200 μg/mL) cells (n = 6). These cells were read in the flow cytometer [Figure 1]b. It was observed that LPS essentially acted in generation of intracellular ROS (red peak). However, BLM (100 and 200 μg/mL) reduced ROS levels (blue peak - 100 μg/mL; white - 200 μg/mL) when compared to LPS-stimulated RAW 264.7 cells (n = 3). The differential fluorescence intensities were recorded by confocal microscopy [Figure 1]c with highest fluorescence in LPS-stimulated cells and a gradual decrease in fluorescence with increasing concentration of BLM (n = 3).
|Figure 1: Effect of Buchanania lanzan on reactive oxygen species (ROS). RAW 264.7 cells were cultured with bark methanol extract (BLM) (10, 50, 100 and 200 ìg/mL) for 24 h and exposed to lipopolysaccharide (LPS) (10 ng/mL) for the last 18 h (a) The intracellular ROS was stained with 5-(and-6) chloromethyl-20,70-dichlorodihydrofluorescein diacetate acetyl ester and BLM significantly (P < 0.05) reduced ROS (a) indicated (**) measured (n = 6). Flow Cytometer analysis of ROS (b) depicts the significantly reduced ROS upon BLM pretreatment (n = 3). The reduced fluorescence intensities due to BLM pretreatment (b-d) compared to LPS-stimulated RAW 264.7 cells (a) was captured (n = 3) by confocal laser scanning microscope (c)|
Click here to view
Based on MTT assay (n = 6), the concentrations of BLM (50, 100 and 200 μg/ml) during the 24 h incubation was not toxic to RAW 264.7 cells [Figure 2]a. Flow Cytometer analysis of BLM (200 μg/mL) treated cells recorded 99.57% viable cells [Figure 2]b. The result on cell viability with neutralization of ROS production due to pretreatment with BLM indicates that the inhibition of the ROS is not due to cell death (n = 3).
|Figure 2: Effect of Buchanania lanzan on cell viability. Cell viability of RAW 264.7 macrophage against B. lanzan methanol extract (BLM) treated with lipopolysaccharide (10 ng/mL) for 18 h was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (a) and results recorded (n = 6). The cells were stained with AM and/or propidium idodide and subjected to analysis by flow cytometer (b) reading viable and dead cells (n = 3)|
Click here to view
Bark methanol extract inhibited nitrite production
Nitrite production was observed to be dependent on the state of the cells. Control cells (unstimulated, minus SNP), produced basal levels of nitrite (4.34 ± 0.23 μM) even after 18 h [Figure 3]a. Addition of BLM did not significantly affect basal nitrite production even at concentrations of 200 μg/mL. When stimulated with SNP (10 μM) for 18 h, induced 17 folds increase in nitrite production to 74.56 ± 1.23 μM [Figure 3]b in comparison to basal levels. In these experiments, addition of BLM (10, 50, 100 and 200 μg/mL), neutralized nitrite accumulation in a concentration-dependent manner to 69.8 ± 5.42, 44.87 ± 3.24, 12.1 ± 2.19 and 9.11 ± 1.32 respectively [Figure 3]b. The effect of BLM inhibition of nitrite production was significantly distinguished with a > 97% decrease at BLM concentration > 100 μg/mL (n = 6).
|Figure 3: Effect of Buchanania lanzan on sodium nitroprusside (SNP)-stimulated nitrite production as a measure of nitric oxide, representative of reactive nitrogen species (RNS), in RAW 264.7 macrophages. RAW 264.7 cells were cultured alone (control) and with bark methanol extract (BLM) (10, 50, 100 and 200 ìg/mL) for 24 h (a) In another group RAW 264.7 cells pretreated with BLM and exposed to SNP (10 ìM) for the last 18 h (b) The nitrite produced due to SNP-stimulation and neutralized by BLM was estimated by Griess reagent. Statistically significant (P < 0.05) neutralization of accumulation of RNS (n = 6) is indicated (**) compared to the control|
Click here to view
Effect of bark methanol extract on inducible nitric oxide synthase protein expression
This experiment was designed to evaluate whether inhibition of production of NO due to pretreatment with BLM was due to inhibition of iNOS protein expression. In this direction, Western blot analysis was performed on whole cell lysates using monoclonal iNOS antibodies as described in materials and methods. A concentration-dependent inhibition of iNOS by BLM was recorded [Figure 4]a. Upon stimulation with SNP (10 μM), an escalated amount of iNOS (4.7 ± 0.61) was produced when compared to un-stimulated cells. However, a pretreatment with 100 and 200 μg/mL BLM, significantly inhibited the levels of iNOS protein [Figure 4]b] by 2.2 ± 1.08 and 0.9 ± 0.48 respectively (n = 3). Cell viability, however, seemed intact in the presence of these concentrations of BLM, as β-actin protein was affected only minimally.
|Figure 4: Effect of Buchanania lanzan on inducible nitric oxide synthase (iNOS) protein expression. RAW 264.7 macrophages were incubated with bark methanol extract (100 and 200 μg/mL) for 24 h and sodium nitroprusside (SNP) (10 μM) for the last 18 h of the experimental duration. Total protein was extracted for iNOS profiling and detected using a iNOS polyclonal antibody. β-actin was incorporated as an internal standard. The band intensities of Western blot (a) were recorded and quantified by densitometer (b) Statistically significant (P < 0.05) reduction in iNOS protein (**) compared to the SNP-stimulated sample (*) is reported n = 3|
Click here to view
Effect of bark methanol extract on inducible nitric oxide synthase mRNA expression
To determine the effect of BLM inhibition of NO production at protein expression or at the level of transcription, RT-PCR was performed to examine the expression profiles of iNOS gene in SNP-stimulated RAW 264.7 macrophages. The housekeeping β-tubulin gene was also amplified from each sample (control, SNP-stimulated, BLM with SNP-stimulated) of the experiment. As shown [Figure 5], RAW 264.7 macrophages do not express detectable levels of iNOS mRNA (control), however stimulation with SNP (10 μM) significantly (P < 0.05) increased iNOS mRNA levels 3.5 ± 0.53 fold relative to β-tubulin gene expression. BLM pretreatment of RAW 264.7 macrophages and subsequent SNP-stimulation indicated a dose-dependent inhibition of iNOS mRNA expression. At 50, 100 and 200 μg/mL of BLM a reduced to the absence of iNOS mRNA level was recorded.
|Figure 5: Effect of Buchanania lanzan on inducible nitric oxide synthase (iNOS) mRNA expression. RAW 264.7 cells were pretreated with bark methanol extract (BLM) (50, 100 and 200 μg/mL) for 24 h and stimulated with sodium nitroprusside (SNP 10 μM) in the last 18 h duration of the experiment. Total RNA from these samples along with control (minus BLM and SNP) was subjected to reverse transcription-polymerase chain reaction. The fold change was calculated based on normalization with β-tubulin gene expression. The analysis was performed with Light Cycler relative quantification software. Statistically significant (P < 0.05) reduction of iNOS mRNA expression (**) is reported in comparison to β-tubulin (n = 3)|
Click here to view
Phytochemical screening of bark methanol extract
Phenolic compounds, a class of metabolites, with excellent antioxidant properties, significantly contributes to pharmaceutical potential of many natural product extracts. The major phenolic compounds in the methanol fraction of BLM were identified by reversed-phase liquid chromatography-diode array detection (RPLC-DAD) screening. Quercetin, HBA and pCA were identified in the methanol fraction of B. lanzan [Figure 6]a in comparison to the retention time of standards, pCA [Figure 6]b; 9.580], quercetin [Figure 6]c; 5.569] and HBA [Figure 6]d; 5.444].
|Figure 6: Reversed-phase liquid chromatography-diode array detection (RPLC-DAD) profile of Buchanania lanzan. The data was obtained with Waters (Milford, MA, USA) Waters Spherisorb column (C18; 250 × 4.6 mm, 50 mm particle size) using Photodiode array detector. Mobile phase (acetonitrile:Water:Acetic acid: 18:82:2) was used at a flow rate of 1 ml/min to run standards, p-coumaric acid (PCA), quercetin and 4-hydroxybenzoic acid (HBA) (200 ppm) with injection volume (10 μL). The RPLC-DAD profile of B. lanzan methanol extract (a) was analyzed to contain PCA (b) quercetin (c) and HBA (d) based on their retention time (n = 3)|
Click here to view
| Discussion|| |
Normal cellular metabolic process involving mitochondrial respiratory chain produces ROS, however, excessive production results in mitochondrial dysfunction as it is reported to inactivate enzymes of Krebs cycle including aconitase and α-ketoglutarate dehydrogenase. , leading to disease conditions. RNS such as NO alone and with superoxide radical, produced under stress conditions, has the capacity to form ONOO− , inhibiting irreversibly mitochondrial respiratory enzymes. ,
Besides the investigation of single compounds, a growing interest persists on application of standardized extracts.  Studies have been devoted to assess the capacity of natural products and consequently attenuating disease conditions involving inhibition of ROS and RNS generation in LPS/SNP-stimulated macrophages. ,,,
Buchanania lanzan, Spr. (Anacardiaceae), with reports on anti-inflammatory conditions ,, was looked into under in vitro conditions in RAW 264.7 murine macrophage cells for the first time. The neutralization of ROS/RNS with inhibition of iNOS has been reported in the present study as a cause for the therapeutic effectiveness of this medicinal plant, bark extract. The therapeutic potential of B. lanzan methanol extract (BLM) has been credited to its capacity to neutralize ROS produced under in vitro conditions when RAW 264.7 cells were stimulated with bacterial LPS measured using CM-H 2 DCFDA, a fluorescent dye to detect intracellular ROS. ,, BLM inhibited accumulation of RNS (NO), estimated as nitrite by Griess reagent when the RAW 264.7 cells were stimulated with SNP. 
Reports on over production of NO, point to the iNOS, as a key enzyme.  Minute quantities of NO produced for physiological functions (by endothelial and neuronal NOS) are reported. However, understanding the mechanism of inhibition of excessive formation of NO has been reported to aid in the development of pharmacological strategies to identify possible herbal/natural/bioactive molecule with therapeutic potential. Hence, researchers have focused on the identification of iNOS catalytic activity  for screening natural products with therapeutic potential.
In the present study, the possible mechanism for reduced accumulation of NO was identified to be reduced iNOS protein expression as assessed by the data obtained with Western blot analysis. Further, data obtained from RT-PCR demonstrated the capacity of BLM to inhibit iNOS expression at the level of its transcript accumulation. As the addition of BLM at higher concentrations (200 μg/ml) did not affect cell viability, as assessed by Flow Cytometer analysis and β-actin, in Western blots experimental procedures, points to the fact that neutralization of ROS/RNS production in LPS/SNP-stimulated RAW 264.7 cells was not due to cell death, however was due to therapeutic effect of BLM.
Plant phytochemicals with health benefits have been attributed to health as they cannot by synthesized by humans  and they have been linked to antioxidant activity.  In the present study, RPLC-DAD identified quercetin, HBA and pCA in BLM. Quercetin is reported as one of the strongest natural anti-inflammatory agent. ,, HBA and pCA were shown to exhibit anti-inflammatory and immuno-modulatory activities in rats. , The presence of the phytochemicals in the extract could also support the therapeutic property B. lanzan bark for mentioned application in The Ayurvedic Pharmacopoeia of India.
| Conclusion|| |
The results validate the use of B. lanzan bark to treat disease conditions. This property was attributed to its ability to neutralize and to quench ROS/RNS produced in RAW 264.7 murine macrophages upon stimulation with LPS/SNP respectively. Further, the ability to inhibit iNOS at protein expression and also at the level of mRNA transcription, B. lanzan extract may represent a strong candidate for development of herbal drug.
| References|| |
Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993;90:7915-22.
Yokozawa T, Chen CP, Tanaka T. Direct scavenging of nitric oxide by traditional crude drugs. Phytomedicine 2000;6:453-63.
Kilbourn RG, Griffith OW. Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992;84:827-31.
Pérez-García F, Marín E, Adzet T, Cañigueral S. Activity of plant extracts on the respiratory burst and the stress protein synthesis. Phytomedicine 2001;8:31-8.
Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446-51.
Rees DD, Cellek S, Palmer RM, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 1990;173:541-7.
Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-61.
Wu CC, Thiemermann C. Biological control and inhibition of induction of nitric oxide synthase. Methods Enzymol 1996;268:408-20.
Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-61.
Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007-11.
Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: A cohort study. BMJ 1996;312:478-81.
Mehta SK, Mukherjee S, Jaiprakash B. Preliminary phytochemical investigation on leaves of Buchanania lanzan
(chironji). Int J Pharm Sci Rev Res 2010;3:55-9.
Nasim KT, Arya R, Babu V, Ilyas M. Myricetin 3'-rhamnoside-3-galactoside from Buchanania lanzan
(Anacardiaceae). Phytochemistry 1992;31:2569-70.
Puri A, Sahai R, Singh KL, Saxena RP, Tandon JS, Saxena KC. Immunostimulant activity of dry fruits and plant materials used in indian traditional medical system for mothers after child birth and invalids. J Ethnopharmacol 2000;71:89-92.
Warokar AS, Ghante MH, Uragkar NJ, Bhusari KP. Anti-inflammatory and antioxidant activities of methanolic extract of Buchanania lanzan
kernel. Indian J Pharm Educ Res 2010;44:363-8.
Patsnaik AK, Kodati D, Pareta SK, Patra KC, Harwansh RK. Analgesic and anti-inflammatory activities of Buchanania lanzan
spreg. Roots. Res J Pharm Biol Chem Sci 2011;2:419-25.
Annonymus. The Ayurvedic Pharmacopoeia of India. Vol. 3. Government of India, Ministry of Health and Family Welfare Department of ISM & H: 2001. p. 122-3.
Shailasree S, Ruma K, Prakash HS. Curative properties of Buchanania lanzan
: As evaluated by its anti-oxidant, anti-inflammatory and DNA protective properties. J Nat Pharm 2012;3:71-7.
Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993;261:1328-30.
Uttenthal LO, Alonso D, Fernández AP, Campbell RO, Moro MA, Leza JC, et al.
Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat. Microsc Res Tech 1998;43:75-88.
Sims NR, Anderson MF, Hobbs LM, Kong JY, Phillips S, Powell JA, et al.
Impairment of brain mitochondrial function by hydrogen peroxide. Brain Res Mol Brain Res 2000;77:176-84.
Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 2001;276:23357-61.
Kirkinezos IG, Moraes CT. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 2001;12:449-57.
Zhang Y, Zhao B. Green tea polyphenols enhance sodium nitroprusside-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. J Neurochem 2003;86:1189-200.
Lee JC, Kim HR, Kim J, Jang YS. Antioxidant property of an ethanol extract of the stem of Opuntia ficus-indica
var. saboten. J Agric Food Chem 2002;50:6490-6.
Tsai TH, Tsai PJ, Ho SC. Antioxidant and anti-inflammatory activities of several commonly used species. J Food Sci 2005;70:93-7.
Schmeda-Hirschmann G, Yesilada E. Traditional medicine and gastroprotective crude drugs. J Ethnopharmacol 2005;100:61-6.
Hernández-Ledesma B, Hsieh CC, de Lumen BO. Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun 2009;390:803-8.
Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo
targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996;97:2377-83.
Chiou WF, Chen CF, Lin JJ. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol 2000;129:1553-60.
Peterson J, Dwyer J. Flavonoids: Dietary occurrence and biochemical activity. Nutr Res 1998;18:1995-2018.
Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem 2001;1:569-90.
Shoskes DA. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: A new class of renoprotective agents. Transplantation 1998;66:147-52.
Inal M, Altinisik M, Bilgin MD. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 2002;20:291-6.
Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, et al. In vivo
quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 2005;35:584-92.
Lim EJ, Kang HJ, Jung HJ, Park EH. Anti-angiogenic, anti-inflammatory and anti-nociceptive activity of 4-hydroxybenzyl alcohol. J Pharm Pharmacol 2007;59:1235-40.
Pragasam SJ, Venkatesan V, Rasool M. Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats. Inflammation 2013;36:169-76.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
|This article has been cited by|
||Antioxidant Activity and Probiotic Properties of Lactic Acid Bacteria
| ||Seonyoung Kim, Ji Yeon Lee, Yulah Jeong, Chang-Ho Kang |
| ||Fermentation. 2022; 8(1): 29 |
|[Pubmed] | [DOI]|
||Antioxidant Effect via Bioconversion of Isoflavonoid in Astragalus membranaceus Fermented by Lactiplantibacillus plantarum MG5276 In Vitro and In Vivo
| ||Ji Yeon Lee, Hye Min Park, Chang-Ho Kang |
| ||Fermentation. 2022; 8(1): 34 |
|[Pubmed] | [DOI]|
||Skin protective and regenerative effects of RM191A, a novel superoxide dismutase mimetic
| ||Artur Shariev, Spiro Menounos, Alistair J. Laos, Pooja Laxman, Donna Lai, Sheng Hua, Anna Zinger, Christopher R. McRae, Llewellyn S. Casbolt, Valery Combes, Greg Smith, Tzong-tyng Hung, Katie M. Dixon, Pall Thordarson, Rebecca S. Mason, Abhirup Das |
| ||Redox Biology. 2021; 38: 101790 |
|[Pubmed] | [DOI]|
||Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction
| ||Tarek S. Ibrahim, Amr H. Moustafa, Ahmad J. Almalki, Rasha M. Allam, Abdulhamid Althagafi, Shadab Md, Mamdouh F. A. Mohamed |
| ||Journal of Enzyme Inhibition and Medicinal Chemistry. 2021; 36(1): 1067 |
|[Pubmed] | [DOI]|
||Antioxidant, Anti-inflammatory, and Antiproliferative Activity of Mori Cortex Radicis Extracts
| ||Al B. Bayazid, Jae G. Kim, Seo H. Park, Beong O. Lim |
| ||Natural Product Communications. 2020; 15(1): 1934578X19 |
|[Pubmed] | [DOI]|
||Biodegradable Hollow Manganese Silicate Nanocomposites to Alleviate Tumor Hypoxia toward Enhanced Photodynamic Therapy
| ||Md Nafiujjaman, Seock-Jin Chung, Irina Kalashnikova, Meghan L. Hill, Silver Homa, Jeron George, Christopher H. Contag, Taeho Kim |
| ||ACS Applied Bio Materials. 2020; 3(11): 7989 |
|[Pubmed] | [DOI]|
||Inhibition of LPS-stimulated ROS production by fluorinated and hydroxylated chalcones in RAW 264.7 macrophages with structure-activity relationship study
| ||Ganesh Bist,Nirmala Tilija Pun,Til Bahadur Thapa Magar,Aarajana Shrestha,Hye Jin Oh,Amrita Khakurel,Pil-Hoon Park,Eung-Seok Lee |
| ||Bioorganic & Medicinal Chemistry Letters. 2017; |
|[Pubmed] | [DOI]|